MAM
PVR INOX Passport hits 20,000 subscribers within weeks of launch
Mumbai: PVR INOX Ltd, India’s leading multiplex chain, today announced that it has achieved the milestone of 20,000 subscriptions of its weekday movie plan, PVR INOX Passport. The milestone marks the completion of sale of the inaugural batch of 20,000 subscriptions. Remarkably, within few weeks of its launch, PVR INOX Passport has witnessed an extraordinary success in the cinema industry. The response to this pioneering program has been overwhelmingly positive, evident by the rapid sale of 20,000 Passports shortly after its grand unveiling. Designed to provide cinephiles with an unparalleled cinematic journey and affordable access to their beloved films, the Passport has swiftly become a phenomenon in the cinema industry
Taking note of this new venture’s success, the brand is already in process of creating a new version of Passport post a careful study of its recent launch and the consumer response. This evolution is not just informed by the valuable insights garnered from consumer behaviour, but also usage patterns observed during the initial phase and the consumer feedback during the process.
Reflecting on the resounding success of the PVR Passport, PVR INOX Ltd co-CEO Gautam Dutta expressed his elation, stating, “We are delighted with the overwhelming response generated during the first phase rollout of 20,000 Passport subscriptions. Our initiative, driven by a commitment to providing an affordable and enriching cinematic experience for all, resonates with movie lovers across India. We are certain that the innovative program will help us add more movie lovers to our fold, and enhance our bond with the movie lovers in our country. We are taking notes of the customer’s like and dislikes on the product and are eager to unveil a more refined iteration of the Passport in the upcoming phase.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
